Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC > Documents
Date Field | Doc. No. | Description (Pages) |
---|---|---|
Jul 20, 2022 | 33 | USCA Notice of Docketing ROA (1) Docket Text: NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [32] Notice of Appeal (Federal Circuit) filed by Eagle Pharmaceuticals, Inc.. USCA Case Number 19-1924 (fms) |
Jul 20, 2022 | N/A | USCA Appeal Fees (0) Docket Text: USCA Appeal Fees received: $505, receipt number 0311-2649875 re [32] Notice of Appeal (Federal Circuit) filed by Eagle Pharmaceuticals, Inc.. (dmp, ) |
Jun 20, 2020 | N/A | Appeal Notification to Reporter Gunning (0) |
Jun 20, 2020 | 14 | Motion for Judgment on the Pleadings (1) |
Jun 20, 2020 | 13 | Motion for Leave to File (2) |
Jun 20, 2020 | 7 | Motion for Leave to File (2) |
Jun 15, 2020 | 35 | Opinion (11) |
Jun 15, 2020 | 35 | USCA Mandate (1) |
Jun 15, 2020 | 35 | Main Document (1) Docket Text: MANDATE of USCA as to [32] Notice of Appeal (Federal Circuit) filed by Eagle Pharmaceuticals, Inc. USCA Decision: affirmed. (Attachments: # (1) Opinion, # (2) Judgment)(nmf) |
Jun 15, 2020 | 35 | Judgment (1) |
May 23, 2019 | 32 | Notice of Appeal* (1) |
May 23, 2019 | N/A | Description not available (0) Docket Text: Notification regarding [32] Notice of Appeal (Federal Circuit) sent to Reporter Gunning (ddp) |
May 23, 2019 | 32 | Notice of Appeal (Federal Circuit) (1) Docket Text: NOTICE OF APPEAL to the Federal Circuit of [31] Memorandum Opinion, [29] Order on Motion for Judgment on the Pleadings, [28] Memorandum Opinion . Appeal filed by Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
May 23, 2019 | N/A | Notice of Appeal and Docket Sheet to USCA (0) Docket Text: Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re [32] Notice of Appeal (Federal Circuit). (ddp) |
May 10, 2019 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 5/10/2019. (Court Reporter V. Gunning.) (nmf) |
May 9, 2019 | 30 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,265,831 B2 ;9,572,796 B2 ;9,572,797 B2 ;10,010,533 B2. (Attachments: # (1) Order granting Motion for Judgment on the Pleadings)(nmf) |
May 9, 2019 | 31 | Memorandum Opinion (16) Docket Text: REVISED MEMORANDUM OPINION re: [28] SEALED MEMORANDUM OPINION; [29] ORDER. Signed by Judge Colm F. Connolly on 5/9/2019. (nmf) |
May 9, 2019 | 30 | Order granting Motion for Judgment on the Pleadings (1) |
May 9, 2019 | 30 | Patent/Trademark Report to Commissioner (1) |
May 9, 2019 | 29 | Order on Motion for Judgment on the Pleadings (1) Docket Text: ORDER granting [14] Motion for Judgment on the Pleadings (CASE CLOSED). Signed by Judge Colm F. Connolly on 5/9/2019. (nmf) |
Mar 1, 2019 | 27 | Redacted Document (16) Docket Text: REDACTED VERSION of [25] Reply Brief by Slayback Pharma LLC. (Ormerod, Eve) |
Feb 25, 2019 | 26 | Request for Oral Argument (1) Docket Text: REQUEST for Oral Argument by Slayback Pharma LLC re [14] MOTION for Judgment on the Pleadings . (Ormerod, Eve) |
Feb 13, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [22] STIPULATION TO EXTEND TIME to submit proposed redacted versions of docket items 20 and 21 to February 12, 2019 filed by Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 2/13/2019. (fms) |
Feb 12, 2019 | 24 | Redacted Document (2) Docket Text: REDACTED VERSION of [21] Declaration by Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
Feb 12, 2019 | 23 | Redacted Document (27) Docket Text: REDACTED VERSION of [20] Answering Brief in Opposition by Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
Feb 12, 2019 | 22 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to submit proposed redacted versions of docket items 20 and 21 to February 12, 2019 - filed by Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
Jan 31, 2019 | N/A | SO ORDERED (0) |
Jan 30, 2019 | 19 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to submit an opposition to Slayback Pharma LLC'S Motion for Judgment on the Pleadings and Reply Brief In Support to February 4, 2019 and February 25, 2019 [D.I. 14] - filed by Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
Jan 14, 2019 | N/A | SO ORDERED (0) |
Jan 11, 2019 | 17 | Redacted Document (14) |
Jan 11, 2019 | 18 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME [Briefing on Motion for Judgment on the Pleadings] to February 1, 2019 and February 22, 2019 - filed by Eagle Pharmaceuticals, Inc.. (Keller, Karen) |
Jan 11, 2019 | 17 | Exhibits A-C (3) |
Jan 11, 2019 | 17 | Main Document (14) Docket Text: REDACTED VERSION of [15] Opening Brief in Support, by Slayback Pharma LLC. (Attachments: # (1) Exhibits A-C)(Ormerod, Eve) |
Jan 9, 2019 | 16 | Order on Motion for Leave to File (1) Docket Text: ORDER granting [13] Motion for Leave to File Under Seal. Signed by Judge Colm F. Connolly on 1/9/2019. (fms) |
Jan 4, 2019 | 14 | Text of Proposed Order (1) |
Jan 4, 2019 | 13 | Text of Proposed Order (1) |
Jan 4, 2019 | 13 | Main Document (2) Docket Text: MOTION for Leave to File Under Seal (Unopposed) - filed by Slayback Pharma LLC. (Attachments: # (1) Text of Proposed Order)(Ormerod, Eve) |
Jan 4, 2019 | 14 | Main Document (1) Docket Text: MOTION for Judgment on the Pleadings - filed by Slayback Pharma LLC. (Attachments: # (1) Text of Proposed Order)(Ormerod, Eve) |
Jan 3, 2019 | 12 | Answer to Counterclaim (13) Docket Text: ANSWER to [8] Answer to Complaint, Counterclaim [ANSWER TO SLAYBACK PHARMA LLC'S COUNTERCLAIMS] by Eagle Pharmaceuticals, Inc..(Keller, Karen) |
Dec 20, 2018 | 11 | Redacted Document (43) |
Dec 20, 2018 | 11 | Exhibit A (1) |
Dec 20, 2018 | 10 | Order on Motion for Leave to File (1) Docket Text: ORDER granting [7] Motion for Leave to File Under Seal. Signed by Judge Colm F. Connolly on 12/20/2018. (nmf) |
Dec 20, 2018 | 11 | Main Document (43) Docket Text: REDACTED VERSION of [8] Answer to Complaint, Counterclaim by Slayback Pharma LLC. (Attachments: # (1) Exhibit A)(Ormerod, Eve) |
Dec 19, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
Dec 13, 2018 | 9 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate KKR & Co. for Slayback Pharma LLC, Slayback Pharma LLC filed by Slayback Pharma LLC. (Belgam, Neal) |
Dec 13, 2018 | 7 | Text of Proposed Order (1) |
Dec 13, 2018 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Eagle Pharmaceuticals, Inc.. Slayback Pharma LLC served on 12/12/2018, answer due 1/2/2019. (Keller, Karen) |
Dec 13, 2018 | 7 | Main Document (2) Docket Text: MOTION for Leave to File Answer, Additional Defenses, Counterclaims and Exhibit thereto Under Seal - filed by Slayback Pharma LLC. (Attachments: # (1) Text of Proposed Order)(Ormerod, Eve) |
Dec 11, 2018 | 1 | Complaint (20) |
Dec 11, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Slayback Pharma LLC on 12/11/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
Dec 11, 2018 | 1 | Main Document (20) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Slayback Pharma LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2522271.) - filed by Eagle Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Civil Cover Sheet)(nmg) |
Dec 11, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Janus Henderson Group PLC for Eagle Pharmaceuticals, Inc. filed by Eagle Pharmaceuticals, Inc.. (nmg) |
Dec 11, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,265,831 B2 ;US 9,572,796 B2 ;US 9,572,797 B2 ;US 10,010,533 B2. (nmg) |
Dec 11, 2018 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/31/2018. Date of Expiration of Patent: 1/28/2031.Thirty Month Stay Deadline: 5/1/2020. (nmg) |
Dec 11, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
Dec 11, 2018 | 1 | Civil Cover Sheet (1) |
Dec 11, 2018 | 1 | Exhibit D (12) |
Dec 11, 2018 | 1 | Exhibit C (10) |
Dec 11, 2018 | 1 | Exhibit B (10) |
Dec 11, 2018 | 1 | Exhibit A (9) |
Dec 11, 2018 | 1 | Complaint* (1) |